-
Kenya’s Maisha Meds Awarded $5 Million by USAID to Help It Scale
Maisha Meds leverages partner funds to incentivise healthcare providers to follow best practices in malaria care.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
New Funding to Ensure 370 Million Children Receive Polio Vaccinations and to Boost Health Innovation in Low-Income Countries
To promote swift progress towards eradicating wild poliovirus, the partnership aims to deliver €500 million in payments to the Global Polio Eradication Initiative – specifically the World Health Organization and UNICEF.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Press Release: Gates Foundation to Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally
This new funding builds on the foundation’s previous US$55 million investment in mRNA manufacturing technology.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
-
Response Statement: Mastercard Foundation and Africa CDC Remain Committed to Saving Lives and Livelihoods
To enable evidence-based planning for the new phase, the Mastercard Foundation and Africa CDC are conducting an audit as part of necessary steps to establish what was achieved in phase one.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
-
Health Workers Stranded as $1.5 Billion Mastercard Vaccine Scheme Halts
Some workers in Nigeria have not been paid for four to six months of their work.
- Categories
- Health Care, Technology
- Region
- Sub-Saharan Africa
- Tags
- COVID-19, public health, vaccines
-
UN Authorizes a Second Malaria Vaccine. Experts Warn It’s Not Enough to Stop the Disease Spreading
Neither of the malaria vaccines stop transmission so immunization campaigns alone won’t be enough to stop epidemics.
- Categories
- Health Care
- Region
- Global
-
mRNA Vaccine Manufacturing Comes to Africa
To run the facility, BioNTech is committed to hiring employees locally and within the African Union.
- Categories
- Coronavirus, Health Care, Technology
- Region
- Sub-Saharan Africa
-
A Pivotal Moment to Invest in Africa: How Impact Investing Can Transform the Continent’s Healthcare Value Chain
The global impact investment market is estimated to be worth US $1.16 trillion, but less than 2% of these investments are channeled to Africa’s health markets. Abiodun Awosusi at the Ivey Business School argues that this should not be the case, as the continent offers uniquely valuable opportunities for health businesses and the investors that support them. He explores the overlapping trends that are driving these opportunities, and shares some ways investors and other stakeholders can get involved.
- Categories
- Health Care, Investing, Social Enterprise
